Instead of bringing you a traditional blog this week, we want to hear from you! Do you have any questions you’d like answered? We are happy to report that we have close to 4000 followers on our weekly blog. We receive many kind comments and appreciation for the information we are sharing. But, we want to make sure we’re answering the questions YOU want answered. Send an email with any questions you might have to cwhiskin@charltonhealthcare.com!
Saphnelo (anifrolumab) is a one-of-a-kind therapy by AstraZeneca for the treatment of moderate to severe…
On December 4, 2023, Health Canada approved Pfizer’s Litfulo (ritlecitinib). Litfulo is a once-daily oral…
Infliximab is a protein-based medication referred to as a biologic that treats many immune-mediated conditions. …
On October 3rd, 2023, Health Canada approved Eli Lilly’s newest biologic for the treatment of…
As February is heart month, today is an excellent occasion to really show why we love our hearts and…
To better serve our Hamilton and area patients, we have expanded and moved our Stoney…
